DaVita Inc. (NYSE:DVA) Shares Bought by Tidal Investments LLC

Tidal Investments LLC increased its stake in DaVita Inc. (NYSE:DVA) by 45.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,688 shares of the company’s stock after purchasing an additional 1,771 shares during the quarter. Tidal Investments LLC’s holdings in DaVita were worth $932,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DVA. Blue Trust Inc. lifted its position in DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after purchasing an additional 78 shares during the period. Atria Wealth Solutions Inc. raised its position in DaVita by 26.7% in the second quarter. Atria Wealth Solutions Inc. now owns 6,068 shares of the company’s stock worth $841,000 after acquiring an additional 1,279 shares in the last quarter. Family Firm Inc. acquired a new stake in DaVita in the 2nd quarter valued at about $43,000. AlphaCentric Advisors LLC grew its stake in shares of DaVita by 75.2% in the 2nd quarter. AlphaCentric Advisors LLC now owns 1,451 shares of the company’s stock worth $201,000 after purchasing an additional 623 shares during the last quarter. Finally, Kintegral Advisory LLC lifted its stake in DaVita by 63.9% during the second quarter. Kintegral Advisory LLC now owns 7,961 shares of the company’s stock valued at $1,103,000 after purchasing an additional 3,105 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 2.9 %

NYSE:DVA opened at $151.85 on Friday. DaVita Inc. has a 1-year low of $103.40 and a 1-year high of $169.51. The firm has a market capitalization of $12.45 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 0.86 and a beta of 0.90. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The business’s fifty day moving average price is $157.18 and its 200 day moving average price is $150.83.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). The company had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.85 earnings per share. On average, sell-side analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Truist Financial lifted their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. Barclays boosted their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.